1059 related articles for article (PubMed ID: 25994453)
41. Acute hepatitis E virus infection in Taiwan 2002-2006 revisited: PCR shows frequent co-infection with multiple hepatitis viruses.
Wu KT; Chung KM; Feng IC; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tang LY; Tsai SL
J Med Virol; 2009 Oct; 81(10):1734-42. PubMed ID: 19697413
[TBL] [Abstract][Full Text] [Related]
42. Seroprevalence of hepatitis E virus among pregnant women and control subjects in China.
Cong W; Sui JC; Zhang XY; Qian AD; Chen J; Zhu XQ
J Med Virol; 2015 Mar; 87(3):446-50. PubMed ID: 25164987
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic.
Lin CC; Wu JC; Chang TT; Chang WY; Yu ML; Tam AW; Wang SC; Huang YH; Chang FY; Lee SD
J Clin Microbiol; 2000 Nov; 38(11):3915-8. PubMed ID: 11060044
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).
Vázquez-Morón S; Berenguer J; González-García J; Jiménez-Sousa MÁ; Canorea I; Guardiola JM; Crespo M; Quereda C; Sanz J; Carrero A; Hontañón V; Avellón A; Resino S
Sci Rep; 2019 Feb; 9(1):1143. PubMed ID: 30718554
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of hepatitis E virus infection in liver transplant recipients.
Haagsma EB; Niesters HG; van den Berg AP; Riezebos-Brilman A; Porte RJ; Vennema H; Reimerink JH; Koopmans MP
Liver Transpl; 2009 Oct; 15(10):1225-8. PubMed ID: 19790147
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of anti-hepatitis E virus immunoglobulin G in HIV-infected individuals over three decades.
Harritshøj LH; Kirkegaard-Klitbo DM; Mejer N; Panum I; Midgley SE; Ullum H; Benfield T
Int J Infect Dis; 2019 Jul; 84():67-72. PubMed ID: 31063824
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?
Rivero-Juarez A; Frias M; Lopez-Lopez P; de Los Angeles Risalde M; Brieva T; Machuca I; Camacho A; Martinez-Peinado A; Gomez-Villamandos JC; Rivero A
Clin Infect Dis; 2017 Apr; 64(7):964-966. PubMed ID: 28077520
[TBL] [Abstract][Full Text] [Related]
48. Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011.
Mansuy JM; Saune K; Rech H; Abravanel F; Mengelle C; L Homme S; Destruel F; Kamar N; Izopet J
Euro Surveill; 2015 May; 20(19):27-34. PubMed ID: 25990359
[TBL] [Abstract][Full Text] [Related]
49. Seroepidemiology and molecular characterization of hepatitis E virus in Jilin, China.
Zhu G; Qu Y; Jin N; Sun Z; Liu T; Lee H; Tian M; Wang T
Infection; 2008 Mar; 36(2):140-6. PubMed ID: 18330507
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis E virus seroprevalence in acute viral hepatitis in a developed country confirmed by a supplemental assay.
Quiroga JA; Cotonat T; Castillo I; Carreño V
J Med Virol; 1996 Sep; 50(1):16-9. PubMed ID: 8890035
[TBL] [Abstract][Full Text] [Related]
51. Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium.
Cattoir L; Van Hoecke F; Van Maerken T; Nys E; Ryckaert I; De Boulle M; Geerts A; Verhelst X; Colle I; Hutse V; Suin V; Wautier M; Van Gucht S; Van Vlierberghe H; Padalko E
J Clin Virol; 2018 Jun; 103():8-11. PubMed ID: 29602096
[TBL] [Abstract][Full Text] [Related]
52. Paediatric liver transplanted patients and prevalence of hepatitis E virus.
Laverdure N; Scholtès-Brunel C; Rivet C; Heissat S; Restier L; Bacchetta J; Boillot O; Dumortier J; Lachaux A
J Clin Virol; 2015 Aug; 69():22-6. PubMed ID: 26209371
[TBL] [Abstract][Full Text] [Related]
53. [A sero-epidemiological study of hepatitis E among general population in Shandong Province of China in 2014].
Yan BY; Zhang L; Lyu JJ; Feng Y; Liu JY; Wu WL; Song LZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):587-592. PubMed ID: 28693081
[No Abstract] [Full Text] [Related]
54. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area.
Wu WC; Su CW; Yang JY; Lin SF; Chen JY; Wu JC
J Med Virol; 2014 Apr; 86(4):720-8. PubMed ID: 24395716
[TBL] [Abstract][Full Text] [Related]
55. Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection.
Gupta E; Pandey P; Pandey S; Sharma MK; Sarin SK
J Clin Virol; 2013 Oct; 58(2):374-7. PubMed ID: 23965185
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis E virus infection in Hong Kong blood donors.
Tsoi WC; Zhu X; To AP; Holmberg J
Vox Sang; 2020 Jan; 115(1):11-17. PubMed ID: 31709559
[TBL] [Abstract][Full Text] [Related]
57. Seroprevalence of hepatitis E virus antibodies in different human populations of Cameroon.
Modiyinji AF; Amougou-Atsama M; Monamele CG; Nola M; Njouom R
J Med Virol; 2019 Nov; 91(11):1989-1994. PubMed ID: 31297845
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years.
Gu G; Huang H; Zhang L; Bi Y; Hu Y; Zhou YH
BMC Infect Dis; 2015 Dec; 15():560. PubMed ID: 26653888
[TBL] [Abstract][Full Text] [Related]
59. Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China.
Zhang L; Jiang Z; Lv J; Liu J; Yan B; Feng Y; Li L; Zhang G; Wang F; Xu A
BMC Infect Dis; 2018 Feb; 18(1):75. PubMed ID: 29433428
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis E virus infection in patients with acute non-A, non-B, non-C hepatitis in Central Brazil.
Freitas NR; Santana EB; Silva ÁM; Silva SM; Teles SA; Gardinali NR; Pinto MA; Martins RM
Mem Inst Oswaldo Cruz; 2016 Nov; 111(11):692-696. PubMed ID: 27759769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
